50.9 F
New York
Saturday, November 28, 2020

Is Now the Time to Invest in NGM Biopharmaceuticals Inc. (NASDAQ:NGM)?

Must read

Turquoise Hill Resources Ltd. (NYSE:TRQ) is Gaining Momentum on Earnings Catalyst

Turquoise Hill Resources Ltd. (TRQ) shares are trading at lower $9.66 and the avg recommendation for the stock is Hold, while the current analyst...

Commerce Bancshares Inc. (NASDAQ:CBSH) on the Path to Ruin

Commerce Bancshares Inc. (CBSH) shares are trading at lower $69.06 and the avg recommendation for the stock is Hold, while the current analyst price...

Can We Expect More Volatility From Ambow Education Holding Ltd. (AMBO)?

Ambow Education Holding Ltd. (AMBO) shares are trading at higher $2.56. To add more color to this target, the company’s high over the last...

CASI Pharmaceuticals Inc. (NASDAQ:CASI) Recent Earnings Shows Major Promise

CASI Pharmaceuticals Inc. (CASI) shares are trading at higher $2.58 and the avg recommendation for the stock is Strong Buy, while the current analyst...

NGM Biopharmaceuticals Inc. (NGM) shares are trading at higher $18.35 and the avg recommendation for the stock is Strong Buy.

To add more color to this target, the company’s high over the last year is $23.95 and the low is $8.81. Over the last 52 weeks, NGM is down -23.38% while the S&P 500 is up 0.22%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, NGM reported a profit of $45.29 million. NGM Biopharmaceuticals Inc. also saw revenues increase to $19.75 million. In addition, NGM has free cash flow of -$39.74 million as of 06-2020. The company’s EBITDA came in at -$23.95 million which compares well with its peers.

NGM booked profit margins of -74.00%, its Return on Equity (ROE) is -22.20%, and its Return on Assets is -19.40%. All told, it is clear that, NGM needs to be on your watchlist.

Find out when NGM reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. NGM has a short ratio of 16.11 and outstanding shares of 68.31M.

Company Outlook

NGM has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 0.18 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -1.06. NGM Biopharmaceuticals Inc. NGM also noted assets of $347.28 million at the end of the last quarter. Investors should also keep an eye on sector updates as NGM has historically followed its peers on positive news.

All told, NGM Biopharmaceuticals Inc. NGM has strung together solid data and demonstrated underlying fundamentals. At its current valuation, NGM represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

NGM Biopharmaceuticals Inc. NGM is now commanding a market cap of 1.31B and a float of 45.23M. NGM is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of NGM stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in NGM, either long or short, and we have not been compensated for this article.

Latest article

The Last Few Sessions Have Adial Pharmaceuticals Inc. (ADIL) Soaring

Adial Pharmaceuticals Inc. (ADIL) shares are trading at higher $1.89 and the avg recommendation for the stock is Moderate Buy. To add more color...

Boqii Holding Limited (NYSE:BQ) Stock is Soaring, Here is Why

Boqii Holding Limited (BQ) shares are trading at higher $6.08 and the avg recommendation for the stock is Moderate Buy. To add more color...

CIT Group Inc. (CIT)’s Stock is Jumping, Here is Why

CIT Group Inc. (CIT) shares are trading at lower $34.99 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

Can We Expect More Volatility From Venator Materials PLC (VNTR)?

Venator Materials PLC (VNTR) shares are trading at lower $2.27 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

When Will CyrusOne Inc. (CONE) Slow Down

CyrusOne Inc. (CONE) shares are trading at higher $70.12 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...